{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=GLPG0634&page=2", "query": { "intervention": "GLPG0634", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=GLPG0634&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-23T02:44:14.815Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01798979", "title": "A Phase I, Open Interaction Study Between GLPG0634 and Midazolam in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "GLPG0634", "type": "DRUG" }, { "name": "Midazolam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lakefront Biotherapeutics NV", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "60 Years", "sex": "MALE", "summary": "40 Years to 60 Years · Male only" }, "enrollment_count": 20, "start_date": "2013-02", "completion_date": "2013-04", "has_results": false, "last_update_posted_date": "2013-05-07", "last_synced_at": "2026-09-23T02:44:14.815Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT01798979" }, { "nct_id": "NCT02886728", "title": "Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Filgotinib", "type": "DRUG" }, { "name": "Placebo to match filgotinib", "type": "DRUG" }, { "name": "MTX", "type": "DRUG" }, { "name": "Placebo to match MTX", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1252, "start_date": "2016-08-08", "completion_date": "2019-05-08", "has_results": true, "last_update_posted_date": "2021-06-01", "last_synced_at": "2026-09-23T02:44:14.815Z", "location_count": 45, "location_summary": "Huntsville, Alabama • Phoenix, Arizona • Tucson, Arizona + 42 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Covina", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02886728" }, { "nct_id": "NCT05479058", "title": "A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in Remission", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "Filgotinib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lakefront Biotherapeutics NV", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 22, "start_date": "2022-07-26", "completion_date": "2023-10-09", "has_results": true, "last_update_posted_date": "2024-10-04", "last_synced_at": "2026-09-23T02:44:14.815Z", "location_count": 5, "location_summary": "Miami, Florida • Naples, Florida • Columbia, Maryland + 2 more", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Naples", "state": "Florida" }, { "city": "Columbia", "state": "Maryland" }, { "city": "Rapid City", "state": "South Dakota" }, { "city": "Chesapeake", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05479058" }, { "nct_id": "NCT01894516", "title": "Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Participants (DARWIN2)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "GLPG0634", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lakefront Biotherapeutics NV", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 287, "start_date": "2013-10-08", "completion_date": "2015-05-29", "has_results": true, "last_update_posted_date": "2020-12-16", "last_synced_at": "2026-09-23T02:44:14.815Z", "location_count": 21, "location_summary": "Gilbert, Arizona • Mesa, Arizona • Phoenix, Arizona + 18 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Hemet", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01894516" }, { "nct_id": "NCT03100942", "title": "Study to Assess Safety and Efficacy of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren's Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sjogren's Syndrome" ], "interventions": [ { "name": "Lanraplenib", "type": "DRUG" }, { "name": "Filgotinib", "type": "DRUG" }, { "name": "Tirabrutinib", "type": "DRUG" }, { "name": "Lanraplenib placebo", "type": "DRUG" }, { "name": "Filgotinib placebo", "type": "DRUG" }, { "name": "Tirabrutinib placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 152, "start_date": "2017-05-01", "completion_date": "2019-10-02", "has_results": true, "last_update_posted_date": "2020-10-23", "last_synced_at": "2026-09-23T02:44:14.815Z", "location_count": 34, "location_summary": "Mesa, Arizona • Phoenix, Arizona • Covina, California + 31 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Covina", "state": "California" }, { "city": "Upland", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03100942" }, { "nct_id": "NCT04115839", "title": "Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriatic Arthritis" ], "interventions": [ { "name": "Filgotinib", "type": "DRUG" }, { "name": "Placebo to match filgotinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 106, "start_date": "2019-11-13", "completion_date": "2021-03-18", "has_results": true, "last_update_posted_date": "2022-03-18", "last_synced_at": "2026-09-23T02:44:14.815Z", "location_count": 22, "location_summary": "Covina, California • DeBary, Florida • Miami, Florida + 19 more", "locations": [ { "city": "Covina", "state": "California" }, { "city": "DeBary", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Palm Harbor", "state": "Florida" }, { "city": "Decatur", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04115839" }, { "nct_id": "NCT03025308", "title": "Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Filgotinib", "type": "DRUG" }, { "name": "Placebo to match filgotinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alfasigma S.p.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2731, "start_date": "2017-02-28", "completion_date": "2025-05-16", "has_results": true, "last_update_posted_date": "2026-07-27", "last_synced_at": "2026-09-23T02:44:14.815Z", "location_count": 72, "location_summary": "Huntsville, Alabama • Gilbert, Arizona • Phoenix, Arizona + 65 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Covina", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03025308" }, { "nct_id": "NCT03077412", "title": "Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Fistulizing Crohn's Disease" ], "interventions": [ { "name": "Filgotinib", "type": "DRUG" }, { "name": "Placebo to match filgotinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 57, "start_date": "2017-04-06", "completion_date": "2021-02-17", "has_results": true, "last_update_posted_date": "2022-04-08", "last_synced_at": "2026-09-23T02:44:14.815Z", "location_count": 13, "location_summary": "Miami, Florida • Orlando, Florida • Tampa, Florida + 10 more", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT03077412" }, { "nct_id": "NCT02914600", "title": "Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "Filgotinib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lakefront Biotherapeutics NV", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1188, "start_date": "2017-03-17", "completion_date": "2023-08-01", "has_results": true, "last_update_posted_date": "2024-07-10", "last_synced_at": "2026-09-23T02:44:14.815Z", "location_count": 100, "location_summary": "Dothan, Alabama • Sun City, Arizona • Coronado, California + 80 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Coronado", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Rialto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02914600" }, { "nct_id": "NCT02914522", "title": "Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "Filgotinib", "type": "DRUG" }, { "name": "PTM filgotinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 1351, "start_date": "2016-11-14", "completion_date": "2020-03-31", "has_results": true, "last_update_posted_date": "2021-04-21", "last_synced_at": "2026-09-23T02:44:14.815Z", "location_count": 61, "location_summary": "Dothan, Alabama • Scottsdale, Arizona • Long Beach, California + 53 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Lone Tree", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02914522" } ] }